| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8271878 | Journal of Geriatric Oncology | 2018 | 8 Pages |
Abstract
CLL and NHL patientsâ¯â¥â¯65 year encounter more toxicities than younger patients even when treated with novel biologic agents. Development of grade three or four hematologic toxicities lead to inferior PFS and OS in NHL but not in CLL.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Michael Tallarico, Jared C. Foster, Drew Seisler, Jacqueline M. Lafky, Arti Hurria, Aminah Jatoi, Harvey J. Cohen, Hyman B. Muss, Nancy Bartlett, Bruce D. Cheson, Sin-Ho Jung, John P. Leonard, John C. Byrd, Chadi Nabhan,